Publications

Guselkumab Decreases Key Cellular Inflammatory Processes Across Ileum and Colon Tissue in Crohn’s Disease

Publié en janvier 2024 AMERICAN JOURNAL OF GASTROENTEROLOGY
janvier 2024

Guselkumab and Golimumab Combination Induction Therapy in Ulcerative Colitis Results in Early Local Tissue Healing That Is Sustained Through Guselkumab Maintenance Therapy

AMERICAN JOURNAL OF GASTROENTEROLOGY
Publication précédente
janvier 2024

IDENTIFICATION AND RANKING OF GENE MODULE ASSOCIATION WITH HISTOLOGIC FEATURES IN ULCERATIVE COLITIS

AMERICAN JOURNAL OF GASTROENTEROLOGY
Publication suivante

Auteurs